DNAprint Genomics (DNAG)

[frogdreaming]

eb0783,

Could you share whatever metrics you used to assess this 'deal'?

I have to say that this is one of the best deals I've ever seen.

What makes it so good?

Some questions that occur to me;

If this drug has the potential that has been reported, why is it on the market for 'only' $2 Million dollars?

Given the money available in the drug acquisition space, (Big Pharma buys up potential drugs by the thousands) why didn't a bidding war ensue that would take it out of DNAP's league in a heartbeat?

Is this drug development a secret?

Does Beth Isreal think that DNAP is the best choice to finish the development and then market their drug?

Wouldn't they have prefered a more substantial player, assuming they had a choice?

Why wasn't there a line at the door waiting to snap up such a potential winner?

In a normal food chain it is usually only the crumbs and the discards that make it down to the little guys, which one is this?

Just curious.

frog